Ledger.Open graph →
SEC Form D · filed October 4, 2018

Tris Pharma, Inc

Offering
$167.5M
Sold
$125.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MONMOUTH JUNCTION, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Peter Ciano · Monmouth Junction, NJExecSmita Mehta · San Diego, CADirectorKetan Mehta · Monmouth Junction, NJExec · DirectorPeter Ciano · Monmouth Junction, NJExecSmita Mehta · San Diego, CADirectorKetan Mehta · Monmouth Junction, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗